Clinical Trial

Artificial Intelligence in Endoscopic Ultrasound

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-19.
Trial Details
NCT Number NCT06564571
Lead Sponsor Orlando Health, Inc.
Conditions Pancreatic Cancer, Pancreas Disease, Pancreatic Cyst
Enrollment 310 participants
Start Date 2024-01-19
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-31